SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002577
Filing Date
2019-04-25
Accepted
2019-04-25 16:03:09
Documents
5
Period of Report
2019-06-14
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238540zdef14a.htm DEF 14A 475586
2 G393208.JPG g393208.jpg GRAPHIC 5903
3 G70128.JPG g70128.jpg GRAPHIC 4505
4 G85462BGI001.GIF g85462bgi001.gif GRAPHIC 107601
5 G85462BGI002.GIF g85462bgi002.gif GRAPHIC 142185
  Complete submission text file 0001047469-19-002577.txt   835517
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33451 | Film No.: 19767401
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences